Publications by authors named "Kent R Johnson"

Claim this Profile
P
Protocol of the randomised placebo controlled pilot trial of the management of acute sciatica (SCIATICA): a feasibility study.
Marissa Nichole Lassere, Kent Robert Johnson, Jeanette Thom, Grant Pickard, Peter Smerdely

BMJ Open· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving quality of care and long-term health outcomes through continuity of care with the use of an electronic or paper patient-held portable health file (COMMUNICATE): study protocol for a randomized controlled trial.
Marissa Nichole Lassere, Sue Baker, Andrew Parle, Anthony Sara, Kent Robert Johnson

Trials· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of vancomycin dosing in very low-birth-weight preterm neonates.
Theresa Madigan, Christine B Teng, Jena Koshaish, Kent R Johnson, Kevin K Graner

Am J Perinatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the Biomarker-Surrogacy (BioSurrogate) Evaluation Schema (BSES).
Marissa N Lassere, Kent R Johnson, Michal Schiff, David Rees

BMC Med Res Methodol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengths and weaknesses of renal markers as risk factors and surrogate markers.
Kent R Johnson

Kidney Int· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE).
Kent R Johnson, Nick Freemantle, Danielle M Anthony, Marissa N D Lassere

J Clin Epidemiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
Kent R Johnson, Marissa N D Lassere

JAMA· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.
Marissa N Lassere, Kent R Johnson, Maarten Boers, Peter Tugwell, Peter Brooks

J Rheumatol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis.
Kent R Johnson, Clare Ringland, Barrie J Stokes, Danielle M Anthony, Nick Freemantle

Lancet Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal disease activity for rheumatoid arthritis: a preliminary definition.
George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, Kent R Johnson

J Rheumatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and progress in adverse event ascertainment and reporting in clinical trials.
Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries

J Rheumatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo

J Rheumatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day

J Rheumatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Power of the database: an international approach to studying longterm rheumatoid arthritis therapy.
Marissa N Lassere, Kent R Johnson

J Rheumatol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombolysis for acute ischaemic stroke: revisiting the evidence.
Kent R Johnson

Med J Aust· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological modelling (including economic modelling) and its role in preventive drug therapy.
Kent R Johnson, Marissa N Lassere

Med J Aust· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis